Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Monogenic mimics of Behçet's disease in the young.

Papadopoulou C, Omoyinmi E, Standing A, Pain CE, Booth C, D'Arco F, Gilmour K, Buckland M, Eleftheriou D, Brogan PA.

Rheumatology (Oxford). 2019 Jan 30. doi: 10.1093/rheumatology/key445. [Epub ahead of print]

PMID:
30715505
2.

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.

Papadopoulou C, Hong Y, Omoyinmi E, Brogan PA, Eleftheriou D.

Brain. 2019 Feb 1. doi: 10.1093/brain/awz005. [Epub ahead of print] No abstract available.

PMID:
30715143
3.

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.

Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M, Deepak S, Dawson P, Eleftheriou D, Harrison K, Hawley D, Heaf E, Leone V, Long E, Maltby S, McErlane F, Rafiq N, Ramanan AV, Riley P, Rangaraj S, Varnier G, Wilkinson N, Pain CE.

Pediatr Rheumatol Online J. 2018 Dec 18;16(1):80. doi: 10.1186/s12969-018-0295-0.

4.

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative.

de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Brogan P, Beresford MW.

Rheumatology (Oxford). 2018 Dec 7. doi: 10.1093/rheumatology/key344. [Epub ahead of print]

PMID:
30535127
5.

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3.

Omoyinmi E, Mohamoud I, Gilmour K, Brogan PA, Eleftheriou D.

Front Immunol. 2018 Nov 1;9:2524. doi: 10.3389/fimmu.2018.02524. eCollection 2018.

6.

Mediterranean diet and its components in relation to all-cause mortality: meta-analysis.

Eleftheriou D, Benetou V, Trichopoulou A, La Vecchia C, Bamia C.

Br J Nutr. 2018 Nov;120(10):1081-1097. doi: 10.1017/S0007114518002593.

PMID:
30401007
7.

Autoinflammation due to homozygous S208 MEFV mutation.

Hong Y, Standing ASI, Nanthapisal S, Sebire N, Jolles S, Omoyinmi E, Verstegen RH, Brogan PA, Eleftheriou D.

Ann Rheum Dis. 2018 Oct 24. pii: annrheumdis-2018-214102. doi: 10.1136/annrheumdis-2018-214102. [Epub ahead of print] No abstract available.

8.

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ.

Lei L, Muhammad S, Al-Obaidi M, Sebire N, Cheng IL, Eleftheriou D, Brogan P.

Pediatr Rheumatol Online J. 2018 Sep 26;16(1):61. doi: 10.1186/s12969-018-0278-1.

9.

Genetic interferonopathies: An overview.

Eleftheriou D, Brogan PA.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):441-459. doi: 10.1016/j.berh.2017.12.002. Epub 2018 Feb 1. Review.

PMID:
29773266
10.

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.

Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, Hong Y, Klein N, Brogan PA.

Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.

11.

Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11.

Keylock A, Hong Y, Saunders D, Omoyinmi E, Mulhern C, Roebuck D, Brogan P, Ganesan V, Eleftheriou D.

Neurology. 2018 Jan 16;90(3):136-138. doi: 10.1212/WNL.0000000000004828. Epub 2017 Dec 20. No abstract available.

12.

Determination of annual and seasonal daytime and nighttime trends of MODIS LST over Greece - climate change implications.

Eleftheriou D, Kiachidis K, Kalmintzis G, Kalea A, Bantasis C, Koumadoraki P, Spathara ME, Tsolaki A, Tzampazidou MI, Gemitzi A.

Sci Total Environ. 2018 Mar;616-617:937-947. doi: 10.1016/j.scitotenv.2017.10.226. Epub 2017 Nov 6.

PMID:
29107377
13.

Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis.

Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, Sen D, Wedderburn LR, Ioannou Y, Hailes S, Eleftheriou D.

JMIR Mhealth Uhealth. 2017 Aug 15;5(8):e121. doi: 10.2196/mhealth.7229.

14.

Vasculitis update: pathogenesis and biomarkers.

Brogan P, Eleftheriou D.

Pediatr Nephrol. 2018 Feb;33(2):187-198. doi: 10.1007/s00467-017-3597-4. Epub 2017 Aug 7. Review.

15.

Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Melo Gomes S, Rowczenio D, Nanthapisal S, Cullup T, Nyanhete R, Ashton E, Murphy C, Clarke M, Ahlfors H, Jenkins L, Gilmour K, Eleftheriou D, Lachmann HJ, Hawkins PN, Klein N, Brogan PA.

PLoS One. 2017 Jul 27;12(7):e0181874. doi: 10.1371/journal.pone.0181874. eCollection 2017.

16.

Microparticles in acute coronary syndrome.

Mavroudis CA, Eleftheriou D, Hong Y, Majumder B, Koganti S, Sapsford R, North J, Lowdell M, Klein N, Brogan P, Rakhit RD.

Thromb Res. 2017 Aug;156:109-116. doi: 10.1016/j.thromres.2017.06.003. Epub 2017 Jun 9.

PMID:
28624718
17.

Necrotic cutaneous vasculitic skin lesions: a case of atypical Henoch-Schönlein purpura in a child with heterozygosity for factor V Leiden.

Dhanjal S, Saso A, Eleftheriou D, Laurent S.

BMJ Case Rep. 2017 May 22;2017. pii: bcr2016218903. doi: 10.1136/bcr-2016-218903. No abstract available.

PMID:
28536112
18.

Decreased antibodies against hepatitis A in previously vaccinated treatment naïve juvenile SLE patients: a prospective case control study.

Maritsi DN, Eleftheriou D, Onoufriou M, Vartzelis G.

Clin Exp Rheumatol. 2017 May-Jun;35(3):544-545. Epub 2017 Mar 8. No abstract available.

PMID:
28281464
19.

Microparticles and their role in coronary artery disease.

Koganti S, Eleftheriou D, Brogan PA, Kotecha T, Hong Y, Rakhit RD.

Int J Cardiol. 2017 Mar 1;230:339-345. doi: 10.1016/j.ijcard.2016.12.108. Epub 2016 Dec 22. Review.

PMID:
28040277
20.

Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.

Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA.

Pediatrics. 2017 Jan;139(1). pii: e20160781. doi: 10.1542/peds.2016-0781. Epub 2016 Dec 21.

21.

Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1.

Standing AS, Malinova D, Hong Y, Record J, Moulding D, Blundell MP, Nowak K, Jones H, Omoyinmi E, Gilmour KC, Medlar A, Stanescu H, Kleta R, Anderson G, Nanthapisal S, Gomes SM, Klein N, Eleftheriou D, Thrasher AJ, Brogan PA.

J Exp Med. 2017 Jan;214(1):59-71. doi: 10.1084/jem.20161228. Epub 2016 Dec 19.

22.

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Khan E, Ambrose NL, Ahnström J, Kiprianos AP, Stanford MR, Eleftheriou D, Brogan PA, Mason JC, Johns M, Laffan MA, Haskard DO.

Sci Rep. 2016 Dec 7;6:38104. doi: 10.1038/srep38104.

23.

Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.

Al-Obaidi M, Saunders D, Brown S, Ramsden L, Martin N, Moraitis E, Pilkington CA, Brogan PA, Eleftheriou D.

Clin Rheumatol. 2016 Oct;35(10):2449-56. doi: 10.1007/s10067-016-3376-9. Epub 2016 Aug 15.

24.

Granulomatosis with polyangiitis mimicking infective endocarditis in an adolescent male.

Varnier GC, Sebire N, Christov G, Eleftheriou D, Brogan PA.

Clin Rheumatol. 2016 Sep;35(9):2369-72. doi: 10.1007/s10067-016-3337-3. Epub 2016 Jul 1.

PMID:
27370964
25.

Complete clinical remission with tocilizumab in two infants with systemic juvenile idiopathic arthritis: a case series.

Maritsi DN, Onoufriou M, Vartzelis G, Eleftheriou D.

Scand J Rheumatol. 2017 Jan;46(1):75-76. doi: 10.3109/03009742.2016.1164243. Epub 2016 May 24. No abstract available.

PMID:
27218706
26.

Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosis.

Murphy C, Nanthapisal S, Gilmour K, Laurent S, D'Arco F, Hemingway C, Brogan P, Eleftheriou D.

Neurology. 2016 May 31;86(22):2109-11. doi: 10.1212/WNL.0000000000002729. Epub 2016 Apr 29. No abstract available.

27.

Therapeutic advances in the treatment of vasculitis.

Eleftheriou D, Brogan PA.

Pediatr Rheumatol Online J. 2016 Apr 26;14(1):26. doi: 10.1186/s12969-016-0082-8. Review.

28.

The lived experience of juvenile idiopathic arthritis in young people receiving etanercept.

Livermore P, Eleftheriou D, Wedderburn LR.

Pediatr Rheumatol Online J. 2016 Apr 12;14(1):21. doi: 10.1186/s12969-016-0083-7.

29.

Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.

Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA.

Arthritis Rheumatol. 2016 Sep;68(9):2314-22. doi: 10.1002/art.39699.

30.

Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK.

Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA.

Rheumatology (Oxford). 2016 Jul;55(7):1263-72. doi: 10.1093/rheumatology/kew029. Epub 2016 Mar 29.

PMID:
27026726
31.

Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study.

Omoyinmi E, Hamaoui R, Bryant A, Jiang MC, Athigapanich T, Eleftheriou D, Hubank M, Brogan P, Woo P.

Pediatr Rheumatol Online J. 2016 Feb 9;14(1):7. doi: 10.1186/s12969-016-0067-7.

32.

Radiologic Improvement After Early Medical Intervention in Localised Facial Morphea.

Khan MA, Shaw L, Eleftheriou D, Prabhakar P, Chong WK, Glover M.

Pediatr Dermatol. 2016 Mar-Apr;33(2):e95-8. doi: 10.1111/pde.12799. Epub 2016 Feb 10.

PMID:
26860318
33.

Paediatric Behçet's disease: a UK tertiary centre experience.

Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.

Clin Rheumatol. 2016 Oct;35(10):2509-16. doi: 10.1007/s10067-016-3187-z. Epub 2016 Feb 1.

34.

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis.

Wu Q, Chaplin H, Ambrose N, Sen D, Leandro MJ, Wing C, Daly N, Webb K, Fisher C, Suffield L, Josephs F, Pilkington C, Eleftheriou D, Al-Obaidi M, Compeyrot-Lacassagne S, Wedderburn LR, Ioannou Y.

Ann Rheum Dis. 2016 Mar;75(3):635-6. doi: 10.1136/annrheumdis-2015-208462. Epub 2015 Dec 29. No abstract available.

35.

Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndrome.

Cruikshank M, Anoop P, Nikolajeva O, Rao A, Rao K, Gilmour K, Eleftheriou D, Brogan PA.

Pediatr Rheumatol Online J. 2015 Nov 16;12 Suppl 1:48. doi: 10.1186/s12969-015-0043-7.

36.

Impaired function of endothelial progenitor cells in children with primary systemic vasculitis.

Hong Y, Eleftheriou D, Klein NJ, Brogan PA.

Arthritis Res Ther. 2015 Oct 16;17:292. doi: 10.1186/s13075-015-0810-3.

37.

Cardiovascular status after Kawasaki disease in the UK.

Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.

Heart. 2015 Oct;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27.

38.

Endothelial Repair in Childhood Arterial Ischaemic Stroke with Cerebral Arteriopathy.

Eleftheriou D, Ganesan V, Hong Y, Klein NJ, Brogan PA.

Cerebrovasc Dis Extra. 2015 Jun 11;5(2):68-74. doi: 10.1159/000381963. eCollection 2015 May-Aug.

39.

Multifocal noninfectious osteitis as a presentation of pediatric granulomatosis with polyangiitis (Wegener's).

Brogan KS, Eleftheriou D, Biassoni L, Sebire N, Brogan PA.

Arthritis Rheumatol. 2015 Oct;67(10):2748. doi: 10.1002/art.39241. No abstract available.

40.

Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom.

Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA.

Arthritis Res Ther. 2015 Feb 25;17:36. doi: 10.1186/s13075-015-0545-1.

41.

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa.

Hampson LV, Whitehead J, Eleftheriou D, Tudur-Smith C, Jones R, Jayne D, Hickey H, Beresford MW, Bracaglia C, Caldas A, Cimaz R, Dehoorne J, Dolezalova P, Friswell M, Jelusic M, Marks SD, Martin N, McMahon AM, Peitz J, van Royen-Kerkhof A, Soylemezoglu O, Brogan PA.

PLoS One. 2015 Mar 30;10(3):e0120981. doi: 10.1371/journal.pone.0120981. eCollection 2015.

42.

Vasculitis in children.

Eleftheriou D, Batu ED, Ozen S, Brogan PA.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i94-103. doi: 10.1093/ndt/gfu393. Epub 2014 Dec 30. Review.

PMID:
25550447
43.

Stimulator of interferon genes-associated vasculitis of infancy.

Omoyinmi E, Melo Gomes S, Nanthapisal S, Woo P, Standing A, Eleftheriou D, Klein N, Brogan PA.

Arthritis Rheumatol. 2015 Mar;67(3):808. doi: 10.1002/art.38998. No abstract available.

44.

Authors' response to 'aspirin dose for treatment of Kawasaki disease'.

Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein N, Brogan P.

Arch Dis Child. 2015 Mar;100(3):300-1. doi: 10.1136/archdischild-2014-307798. Epub 2014 Nov 25. No abstract available.

PMID:
25425602
45.

Bayesian methods for the design and interpretation of clinical trials in very rare diseases.

Hampson LV, Whitehead J, Eleftheriou D, Brogan P.

Stat Med. 2014 Oct 30;33(24):4186-201. doi: 10.1002/sim.6225. Epub 2014 Jun 23.

46.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.

Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M.

Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11.

47.

Polyarticular septic arthritis in an 11-year-old child.

Campanilho-Marques R, Novelli V, Brogan PA, Eleftheriou D.

Clin Rheumatol. 2014 Aug;33(8):1181-2. doi: 10.1007/s10067-014-2496-3. Epub 2014 Jan 22.

PMID:
24449284
48.

Brief Report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndrome.

Omoyinmi E, Melo Gomes S, Standing A, Rowczenio DM, Eleftheriou D, Klein N, Aróstegui JI, Lachmann HJ, Hawkins PN, Brogan PA.

Arthritis Rheumatol. 2014 Jan;66(1):197-202. doi: 10.1002/art.38217.

49.

The coming of age of adolescent rheumatology.

Eleftheriou D, Isenberg DA, Wedderburn LR, Ioannou Y.

Nat Rev Rheumatol. 2014 Mar;10(3):187-93. doi: 10.1038/nrrheum.2013.202. Epub 2014 Jan 7. Review.

PMID:
24394351
50.

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.

Russo RA, Melo-Gomes S, Lachmann HJ, Wynne K, Rajput K, Eleftheriou D, Edelsten C, Hawkins PN, Brogan PA.

Rheumatology (Oxford). 2014 Apr;53(4):665-70. doi: 10.1093/rheumatology/ket415. Epub 2013 Dec 17.

PMID:
24352339

Supplemental Content

Loading ...
Support Center